RenovoRx, Inc. (RNXT)
NASDAQ: RNXT · Real-Time Price · USD
1.210
0.00 (0.00%)
Nov 21, 2024, 2:11 PM EST - Market open

RenovoRx Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2023 FY 2022 FY 2021 FY 2020 FY 2019
Period Ending
Sep '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19
Selling, General & Admin
4.895.735.652.630.820.9
Research & Development
5.225.674.33.042.393
Operating Expenses
10.1211.49.955.673.23.9
Operating Income
-10.12-11.4-9.95-5.67-3.2-3.9
Interest Expense
----0.83-0.59-
Interest & Investment Income
0.310.110.06--0.06
Other Non Operating Income (Expenses)
0.641.0600.12-0.01-0.01
EBT Excluding Unusual Items
-9.16-10.23-9.89-6.39-3.8-3.84
Other Unusual Items
---0.06--
Pretax Income
-9.16-10.23-9.89-6.32-3.8-3.84
Net Income
-9.16-10.23-9.89-6.32-3.8-3.84
Net Income to Common
-9.16-10.23-9.89-6.32-3.8-3.84
Shares Outstanding (Basic)
19109522
Shares Outstanding (Diluted)
19109522
Shares Change (YoY)
88.79%13.69%73.50%135.64%1.69%-
EPS (Basic)
-0.49-0.99-1.09-1.21-1.72-1.76
EPS (Diluted)
-0.49-0.99-1.09-1.21-1.72-1.76
Free Cash Flow
-8.75-10.26-8.81-5.93-3.53-3.35
Free Cash Flow Per Share
-0.47-1.00-0.97-1.14-1.59-1.54
EBITDA
--11.39-9.94-5.66--
D&A For EBITDA
-0.010.010.01--
EBIT
-10.12-11.4-9.95-5.67-3.2-3.9
Source: S&P Capital IQ. Standard template. Financial Sources.